Filing Flows › Integrated Biopharma (INBP) › Operating margin
Integrated Biopharma (INBP) operating margin by quarter
Integrated Biopharma's operating margin was 1.3% in Q1 FY26 (first quarter fiscal 2026), -4.0 pts from Q3 FY25. Over the last 3 quarters it ranged from 1.3% (Q1 FY26) to 5.3% (Q3 FY25).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY26 | 1.3% | -4.0 pts | — |
| Q3 FY25 | 5.3% | +3.7 pts | — |
| Q2 FY25 | 1.6% | — | — |
Q1 FY26 at a glance
Integrated Biopharma, Q1 FY26: revenue $12.7M (-7% year over year), operating margin 1.3%, net earnings $123K, operating cash flow $1.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Integrated Biopharma's operating margin?
Integrated Biopharma's operating margin was 1.3% in Q1 FY26 (first quarter fiscal 2026), -4.0 pts from Q3 FY25.
How has Integrated Biopharma's operating margin changed?
Over the last 3 quarters it ranged from 1.3% (Q1 FY26) to 5.3% (Q3 FY25).